Inactive Instrument
Pandion Therapeutics, Inc. Stock
Stocks
PAND
US6983401067
Biotechnology & Medical Research
| 1 day | +0.22% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gregg Beloff
DFI | Director of Finance/CFO | 58 | - |
| Chief Tech/Sci/R&D Officer | - | 01/08/2020 | |
Edward Freedman
COO | Chief Operating Officer | 57 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/04/21 | Tender | Director | 91,738 | 0.3108% | ||
| 01/04/21 | Polaris Growth Management LLC
| Tender | Company | 3,201,422 | 10.8465% | |
| 01/04/21 | Tender | Executive/Senior Manager | 189,780 | 0.6430% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.22% | +0.13% | - | - | 1.7B | |
| -4.10% | -8.35% | +38.48% | +66.99% | 66.22B | |
| -0.41% | +4.99% | +7.61% | +72.82% | 55.2B | |
| +0.74% | +7.31% | +12.50% | +88.71% | 52.79B | |
| +0.61% | +2.69% | +27.75% | +51.50% | 45.53B | |
| -1.08% | +2.19% | +21.92% | +126.56% | 43.94B | |
| -3.39% | -0.83% | +254.27% | +922.56% | 41.64B | |
| -1.67% | +8.06% | +14.17% | +56.67% | 34B | |
| -8.38% | -9.01% | +25.65% | -1.82% | 25.84B | |
| +1.30% | +6.97% | +38.37% | +28.59% | 23.51B | |
| Average | -1.58% | +3.43% | +48.97% | +156.95% | 43.19B | |
| Weighted average by Cap. | -1.64% | +3.43% | +47.57% | +159.55% |
Employees
56
